shopping cart Your cart is empty
  • Home
  • Pharmaceutical
  • Contraceptive Market By Product (Contraceptive Drugs, Contraceptive Devices), Industry Size, Growth, Share And Forecast To 2022

Contraceptive Market By Product (Contraceptive Drugs, Contraceptive Devices), Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Mar 10, 2016

Key findings

 

The global contraceptive market is estimated to grow at 4.3% during 2015-2022 and is estimated to be $32.85 billion by 2022. Increasing prevalence of sexually transmitted diseases and growing need for population control. The global contraceptive market is majorly driven by various factors such as growing prevalence of sexually transmitted infections (STIs), such as HIV. The introduction of new products, exhibiting improved efficacy are expected to drive the contraceptive market over the forecast period. Awareness programs run by government and NGOs to promote the use of contraceptives across the globe are also contributing positively to the growth of contraceptive market. However ethical and social issues are some major factors restricting the use contraceptives in some countries like Middle-East. In addition, rising prevalence of infertility among women and aging population are limiting the use of contraceptives thereby restricting the market growth.

 

Market segment insight

 

The application market for contraceptives is segmented by products and geography. Segmentation by product is further divided into drugs, such as topical contraceptives, injectable, and oral contraceptive pills. Out of all the segments, contraceptive devices hold the biggest market share, at about 62%, presently. The primary reason for the growth of this segment is the growthofcontraceptive devices such as copper IUDs, male condoms, and inexpensive sub-dermal contraceptive implants which is also known as sino-implants. In addition, the sub-segment comprises of male contraceptive devices (such as condoms) and female contraceptive devices such as female condoms, sub-dermal contraceptive implants, intrauterine devices, contraceptive diaphragm, contraceptive sponges, contraceptive vaginal rings and non-surgical permanent contraception device.

 

Regional insight

 

Presently North America dominates the global contraceptive market with 32.0% market share due to the high incidence rates of abortion, rising population of women within the age group of 15-44 years, and high patient awareness levels in the region. The European contraceptives also witness a high penetration of products in some segments like IUD and subdermal implants. Latin American market is an emerging market with great opportunities due to its untapped nature, constantly improving healthcare infrastructure, economic development, and rising patient awareness. Regionally, Asia-Pacific has potential to influence the industry in terms of demographics and lack of awareness within the large population. Favorable government initiatives pertaining to sex education of individuals are one of the key factors expected to push the contraceptive market over the forecasted period.

 

Competitive insight

 

The key players in Global Contraceptive market include Teva Pharmaceutical Industries, The Female Health Company, Reckitt Benckiser Plc, Pfizer Inc., Church & Dwight, Mayer Laboratories, Cooper Surgical, Actavis plc, and Merck & Co.etc. The market has high level of competition and remains the same during the forecasted period with constant pressure on players to launch new products.

 

Reasons for buying the report

 

  • This report provides a detailed study of current trends in the Global Contraceptive market, key growth drivers, and restraints.
  • It provides market forecast for the next 7 years (2015-2022) assessed on the basis of market growth.
  • The report also includes analysis of recent technological developments in the global contraceptive market, analysis of key market players and the key winning strategy adopted and predictive analysis.
  • The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
  • The report tracks and analyse the changing market dynamics.
  • The report also talks about emerging opportunities in the market and the future impact of major drivers and restraints of the market.
  • The report also provides extensive analysis with respect to key product segments.
  • The analysis in the report will help in making effective business decisions.
  • It provides analysis through distinctive graphs and charts and analyses strengths, weakness, opportunities and threats of major market players.

1. Methodology & Scope
    1.1. Research Methodology
    1.2. Research Scope & Assumptions
    1.3. List of Data Sources

 

2. Executive Summary
    2.1. Global Contraceptive Market – Industry summary & key buying criteria
    2.2. Global Contraceptive Market industry outlook
    2.3. Market segmentation Analysis
    2.4. Market size and growth prospects 2012-2022
    2.5. Global Contraceptive Market industry value chain analysis
    2.6. Vendor Landscape

 

3. Global Contraceptive Market Dynamics
    3.1. Market driver analysis
        3.1.1. Awareness programs run by government and NGOs to promote the use of contraceptives across the globe
        3.1.2. Implementation of the Patient Protection Act or the Affordable Care Act increased the use of contraceptives in North America
    3.2. Market restraint analysis
        3.2.1. Ethical and social issues restrict the use or subsidies on contraceptives in some countries like middle east region
        3.2.2. Rising prevalence of infertility among women and aging population are limiting the use of contraceptives
    3.3. Key opportunities prioritized
        3.3.1. Presence of strong contraceptive pipeline is expected to support the global contraceptives market
        3.3.2. Presence of large unfulfilled contraceptive demand in emerging Asian and African Economies

 

4. Industry analysis
    4.1. Global Contraceptive Market Porter’s 5 analysis
    4.2. Global Contraceptive Market – PESTEL analysis
    4.3. Global Contraceptive Market – GAP analysis

 

5. Global Contraceptive Market By Product Type 2012-2022 ($ billion)
    5.1. Global Contraceptive Drugs market
        5.1.1. Global Contraceptive Drugs market 2012-2022 ($ billion)
        5.1.2. Global Oral Contraceptive Pills market
            5.1.2.1. Global Oral Contraceptive Pills market 2012-2022 ($ billion)
            5.1.2.2. Global Contraceptive Injectable market
                5.1.2.2.1. Global Contraceptive injectable market 2012-2022 ($ billion)
            5.1.2.3. Global Topical Contraceptives market
                5.1.2.3.1. Global Topical Contraceptives market 2012-2022 ($ billion)
    5.2. Global Contraceptive Devices market
        5.2.1. Global Contraceptive Devices market 2012-2022 ($ billion)
        5.2.2. Global Male Contraceptive Devices (Male Condoms)market
            5.2.2.1. Global Male Contraceptive Devices (Male Condoms) market 2012-2022 ($ billion)
        5.2.3. Global Female Contraceptive Devicesmarket
            5.2.3.1. Global Female Contraceptive Devices market 2012-2022 ($ billion)
            5.2.3.2. Global Contraceptive Diaphragms market
                5.2.3.2.1. Global Contraceptive Diaphragms market 2012-2022 ($ billion)
            5.2.3.3. Global Contraceptive Sponges market
                5.2.3.3.1. Global Contraceptive Sponges market 2012-2022 ($ billion)
            5.2.3.4. Global Contraceptive Vaginal Rings market
                5.2.3.4.1. Global Contraceptive Vaginal Rings market 2012-2022 ($ billion)
            5.2.3.5. Global Intrauterine Devices market
                5.2.3.5.1. Global Intrauterine Devices market 2012-2022 ($ billion)
            5.2.3.6. Global Subdermal Contraceptive Implants market
                5.2.3.6.1. Global Subdermal Contraceptive Implants market 2012-2022 ($ billion)
            5.2.3.7. Global Non-Surgical Permanent Contraception Devices market
                5.2.3.7.1. Global Non-Surgical Permanent Contraception Devices market 2012-2022 ($ billion)

 

6. Global Contraceptive Market regional outlook 2012-2022 ($ billion)
    6.1. Global Contraceptive Market volume share by region 2012-2022 ($ billion)
    6.2. North America
        6.2.1. North America market estimates and forecast 2012-2022 ($ billion)
        6.2.2. North America market estimates and forecast by region 2012-2022 ($ billion)
        6.2.3. North America market estimates and forecast by application 2012-2022 ($ billion)
            6.2.3.1. U.S.
                6.2.3.1.1. U.S. market estimates and forecast 2012-2022 ($ billion)
                6.2.3.1.2. U.S. market estimates and forecast by application 2012-2022 ($ billion)
            6.2.3.2. Canada
                6.2.3.2.1. Canada market estimates and forecast 2012-2022 ($ billion)
                6.2.3.2.2. Canada market estimates and forecast by application 2012-2022 ($ billion)
            6.2.3.3. Mexico
                6.2.3.3.1. Mexico market estimates and forecast 2012-2022 ($ billion)
                6.2.3.3.2. Canada market estimates and forecast by application 2012-2022 ($ billion)
    6.3. Europe
        6.3.1. Europe market estimates and forecast 2012-2022 ($ billion)
        6.3.2. Europe market estimates and forecast by region 2012-2022 ($ billion)
        6.3.3. Europe market estimates and forecast by application 2012-2022 ($ billion)
            6.3.3.1. Germany
                6.3.3.1.1. Germany market estimates and forecast 2012-2022 ($ billion)
                6.3.3.1.2. Germany market estimates and forecast by application 2012-2022 ($ billion)
            6.3.3.2. UK
                6.3.3.2.1. UK market estimates and forecast 2012-2022 ($ billion)
                6.3.3.2.2. UK market estimates and forecast by application 2012-2022 ($ billion)
            6.3.3.3. Russia
                6.3.3.3.1. Russia market estimates and forecast 2012-2022 ($ billion)
                6.3.3.3.2. Russia market estimates and forecast by application 2012-2022 ($ billion)
    6.4. Asia Pacific
        6.4.1. Asia Pacific market estimates and forecast 2012-2022 ($ billion)
        6.4.2. Asia Pacific market estimates and forecast by region 2012-2022 ($ billion)
        6.4.3. Asia Pacific market estimates and forecast by application 2012-2022 ($ billion)
            6.4.3.1. China
                6.4.3.1.1. China market estimates and forecast 2012-2022 ($ billion)
                6.4.3.1.2. China market estimates and forecast by application 2012-2022 ($ billion)
            6.4.3.2. India
                6.4.3.2.1. India market estimates and forecast 2012-2022 ($ billion)
                6.4.3.2.2. India market estimates and forecast by application 2012-2022 ($ billion)
            6.4.3.3. South Korea
                6.4.3.3.1. South Korea market estimates and forecast 2012-2022 ($ billion)
                6.4.3.3.2. South Korea market estimates and forecast by application 2012-2022 ($ billion)
    6.5. Middle East & Africa
        6.5.1. Middle East & Africa market estimates and forecast 2012-2022 ($ billion)
        6.5.2. Middle East & Africa market estimates and forecast by application 2012-2022 ($ billion)
    6.6. Central &South America
        6.6.1. Central & South America market estimates and forecast 2012-2022 ($ billion)
        6.6.2. Central & South America market estimates and forecast by application 2012-2022 ($ billion)
            6.6.2.1. Brazil
                6.6.2.1.1. Brazil market estimates and forecast 2012-2022 ($ billion)
                6.6.2.1.2. Brazil market estimates and forecast by application 2012-2022 ($ billion)

 

7. Competitive Landscape
    7.1. Actavis, Inc.
        7.1.1. Company Overview
        7.1.2. Financial Performance
        7.1.3. Product Benchmarking
        7.1.4. Strategic Initiatives
    7.2. Bayer AG
        7.2.1. Company Overview
        7.2.2. Financial Performance
        7.2.3. Product Benchmarking
        7.2.4. Strategic Initiatives
    7.3. Church & Dwight Co., Inc.
        7.3.1. Company Overview
        7.3.2. Financial Performance
        7.3.3. Product Benchmarking
        7.3.4. Strategic Initiatives
    7.4. CooperSurgical, Inc.
        7.4.1. Company Overview
        7.4.2. Financial Performance
        7.4.3. Product Benchmarking
        7.4.4. Strategic Initiatives
    7.5. Mayer Laboratories, Inc.
        7.5.1. Company Overview
        7.5.2. Financial Performance
        7.5.3. Product Benchmarking
        7.5.4. Strategic Initiatives
    7.6. Merck & Co., Inc.
        7.6.1. Company Overview
        7.6.2. Financial Performance
        7.6.3. Product Benchmarking
        7.6.4. Strategic Initiatives
    7.7. Pfizer, Inc.
        7.7.1. Company Overview
        7.7.2. Financial Performance
        7.7.3. Product Benchmarking
        7.7.4. Strategic Initiatives
    7.8. Reckitt Benckiser plc
        7.8.1. Company Overview
        7.8.2. Financial Performance
        7.8.3. Product Benchmarking
        7.8.4. Strategic Initiatives
    7.9. Teva Pharmaceutical Industries Ltd.
        7.9.1. Company Overview
        7.9.2. Financial Performance
        7.9.3. Product Benchmarking
        7.9.4. Strategic Initiatives
    7.10. The Female Health Company
        7.10.1. Company Overview
        7.10.2. Financial Performance
        7.10.3. Product Benchmarking
        7.10.4. Strategic Initiatives
    7.11. Mankind
        7.11.1. Company Overview
        7.11.2. Financial Performance
        7.11.3. Product Benchmarking
        7.11.4. Strategic Initiatives
    7.12. TTK-LIG
        7.12.1. Company Overview
        7.12.2. Financial Performance
        7.12.3. Product Benchmarking
        7.12.4. Strategic Initiatives
    7.13. HLL Lifecare Limited
        7.13.1. Company Overview
        7.13.2. Financial Performance
        7.13.3. Product Benchmarking
        7.13.4. Strategic Initiatives
    7.14. Pace Pharmaceuticals Inc
        7.14.1. Company Overview
        7.14.2. Financial Performance
        7.14.3. Product Benchmarking
        7.14.4. Strategic Initiatives

1. Global Contraceptive Drugs market 2012-2022 ($ billion)
2. Global Oral Contraceptive Pills market 2012-2022 ($ billion)
3. Global Contraceptive injectable market 2012-2022 ($ billion)
4. Global Topical Contraceptives market 2012-2022 ($ billion)
5. Global Contraceptive Devices market 2012-2022 ($ billion)
6. Global Male Contraceptive Devices (Male Condoms) market 2012-2022 ($ billion)
7. Global Female Contraceptive Devices market 2012-2022 ($ billion)
8. Global Contraceptive Diaphragms market 2012-2022 ($ billion)
9. Global Contraceptive Sponges market 2012-2022 ($ billion)
10. Global Contraceptive Vaginal Rings market 2012-2022 ($ billion)
11. Global Intrauterine Devices market 2012-2022 ($ billion)
12. Global Subdermal Contraceptive Implants market 2012-2022 ($ billion)
13. Global Non-Surgical Permanent Contraception Devices market 2012-2022 ($ billion)

1. Global Contraceptive Market share 2012-2022 ($ billion)
2. Market Share by regions
3. United States market estimates and forecast 2012-2022 ($ billion)
4. Canada market estimates and forecast 2012-2022 ($ billion)
5. Mexico market estimates and forecast 2012-2022 ($ billion)
6. UK market estimates and forecast 2012-2022 ($ billion)
7. France market estimates and forecast 2012-2022 ($ billion)
8. Germany market estimates and forecast 2012-2022 ($ billion)
9. APAC market estimates and forecast 2012-2022 ($ billion)
10. China market estimates and forecast 2012-2022 ($ billion)
11. India market estimates and forecast 2012-2022 ($ billion)
12. Middle East & Africa market estimates and forecast 2012-2022 ($ billion)
13. Central & South America market estimates and forecast 2012-2022 ($ billion)
14. Brazil market estimates and forecast 2012-2022 ($ billion)

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)